Status:
COMPLETED
Study of Clinical Course of Newly Diagnosed Moderate to Severe Ulcerative Colitis in Korea
Lead Sponsor:
Janssen Korea, Ltd., Korea
Conditions:
Colitis, Ulcerative
Eligibility:
All Genders
7+ years
Brief Summary
The purpose of this study is to describe clinical course of newly diagnosed moderate to severe ulcerative colitis (chronic inflammatory disease of the colon) in tertiary referral hospitals in Korea fo...
Detailed Description
This is a multicenter (when medical research study takes place in more than one country), prospective (study following participants forward in time), disease-oriented and hospital-based 5-year follow-...
Eligibility Criteria
Inclusion
- Participant is newly diagnosed with moderate to severe ulcerative colitis in a tertiary referral hospital within 4 weeks prior to enrollment
- The diagnosis was based on symptoms consistent with ulcerative colitis lasting for more than 4 weeks, excluding infections and other acute or chronic non-infectious bowel syndrome conditions
- Participants meet diagnostic criteria for ulcerative colitisif at least 3 out of 4 of the following are met: 1) A History of diarrhea and/or blood/pus in stool, 2) Macroscopic appearance at endoscopy, with continuous mucosal inflammation affecting the rectum in continuity with some or all of the colon, 3) Microscopic features on biopsy consistent with ulcerative colitis, 4) No suspicion of Crohn's disease or indeterminate colitis
- Participants are willing to participate in regular follow-up visits
- Participant is willing to participate in the study and has signed the informed consent
Exclusion
- Participants in an interventional clinical trial with systemic corticosteroid, biologics (including, but not limited to, infliximab, golimumab, adalimumab and vedolizumab, etc) and other drugs (sulfasalazine, medalamine, azathioprine, tofacitinib, etc) for ulcerative colitis
- Having experienced colectomy such as subtotal colectomy with ileorectostomy or colectomy with ileoanal pouch, Koch pouch, or ileostomy for ulcerative colitis, or planning surgical treatment within 1 year from enrollment
- A current diagnosis of indeterminate colitis, or current diagnosis or history of Crohn's disease
Key Trial Info
Start Date :
July 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 22 2022
Estimated Enrollment :
368 Patients enrolled
Trial Details
Trial ID
NCT02229344
Start Date
July 1 2014
End Date
February 22 2022
Last Update
April 27 2025
Active Locations (15)
Enter a location and click search to find clinical trials sorted by distance.
1
Ansan-si, South Korea
2
Busan, South Korea
3
Cheonan, South Korea
4
Cheongju-si, South Korea